No single eosinophil level confirms cancer. Eosinophils are a type of white blood cell, and while certain cancers can drive them very high, so can allergies, parasitic infections, and autoimmune conditions. The threshold that typically triggers investigation for a possible malignancy is an absolute eosinophil count (AEC) above 1,500 cells per microliter, sustained over time, especially when common causes like allergies and infections have been ruled out.
Normal Eosinophil Counts vs. Elevated
In healthy adults, the median eosinophil count is around 100 cells per microliter of blood. Counts above roughly 400 to 450 cells/μL fall outside the normal range, based on the 95th percentile in large population studies. Once eosinophils cross 500 cells/μL, clinicians categorize the elevation into three tiers:
- Mild eosinophilia: 500 to 1,500 cells/μL
- Moderate eosinophilia: 1,500 to 5,000 cells/μL
- Severe eosinophilia: above 5,000 cells/μL
Mild eosinophilia is extremely common and usually caused by allergies, asthma, or eczema. The higher the count and the longer it persists, the more likely a serious underlying cause, including cancer, becomes part of the investigation.
The 1,500 Threshold and Cancer Concern
A sustained AEC of 1,500 cells/μL or higher on at least two blood tests taken two or more weeks apart meets the formal definition of hypereosinophilia. This is the level where cancer-related causes enter the differential diagnosis more seriously. A recent analysis found that using 1,500 cells/μL as a referral cutoff captured 97% of patients who ultimately had a clinically meaningful eosinophilic disorder, including blood cancers.
That said, reaching 1,500 does not mean you have cancer. It means the elevation is significant enough to warrant further testing beyond the basics. Many people with counts in this range still have non-cancerous explanations, particularly drug reactions, parasitic infections, or inflammatory bowel disease.
Counts above 5,000 cells/μL raise more urgent concern. At that level, clinicians typically fast-track evaluation for blood cancers like chronic eosinophilic leukemia or hypereosinophilic syndrome, especially if there are signs of organ damage to the heart, lungs, or skin.
Blood Cancers That Directly Involve Eosinophils
Some blood cancers cause the bone marrow itself to overproduce eosinophils. Chronic eosinophilic leukemia is the most direct example. It’s diagnosed when eosinophils make up 30% or more of the cells in the blood or bone marrow, and the eosinophils carry genetic mutations confirming they’re part of a cancerous clone. Hypereosinophilic syndrome (HES) is a related condition where persistently high eosinophils damage organs, though not all cases of HES are cancerous.
These conditions often push eosinophil counts well above 5,000 cells/μL and can cause symptoms like fatigue, fevers, skin rashes, cough, shortness of breath, and heart problems. In the myeloid (bone marrow-driven) form, patients tend to be male and may have an enlarged spleen, elevated vitamin B12 levels, and abnormal-looking eosinophils on a blood smear.
Solid Tumors That Raise Eosinophils
Some solid tumors release signaling molecules that stimulate eosinophil production even though the cancer itself isn’t in the blood. This is called paraneoplastic eosinophilia, and the counts can be strikingly high. A review of 100 reported cases found average eosinophil counts ranging from about 5,000 to over 76,000 cells/μL depending on the tumor type.
Lung cancers are among the most frequently reported. Large cell carcinoma of the lung had an average AEC of roughly 62,000 cells/μL in reported cases, with peaks above 125,000. Colon cancer averaged around 40,000. Other tumor types linked to paraneoplastic eosinophilia include:
- Stomach and pancreatic cancers: averages of 14,000 to 17,000 cells/μL
- Kidney cancers: averages of 16,000 to 45,000 cells/μL
- Thyroid cancers: averages of 20,000 to 44,000 cells/μL
- Uterine sarcomas: average around 45,000 cells/μL
- Metastatic melanoma: average around 76,000 cells/μL
- Liver, prostate, and bladder cancers: averages ranging from 6,000 to 21,000 cells/μL
These are averages from published case reports, which tend to capture the most dramatic examples. Still, the pattern is clear: cancer-associated eosinophilia typically produces counts far above 1,500 and often above 10,000. A mildly elevated count in the 500 to 1,500 range, while worth monitoring, is far less likely to point to a tumor.
Far More Common Causes of High Eosinophils
Cancer is a relatively rare explanation for elevated eosinophils. The two most common causes are parasitic infections and allergic reactions to medications. Beyond those, a long list of non-cancerous conditions can raise eosinophil counts:
- Allergic conditions: asthma, hay fever, eczema, food allergies
- Parasitic infections: roundworm, hookworm, and other worm infections
- Inflammatory bowel disease: Crohn’s disease and ulcerative colitis
- Autoimmune conditions: including a condition affecting blood vessels called eosinophilic granulomatosis with polyangiitis
- Skin disorders: various inflammatory skin conditions
- Adrenal insufficiency: when the adrenal glands don’t produce enough cortisol
- Eosinophilic esophagitis: inflammation of the esophagus driven by eosinophils
If you have a known history of allergies or asthma, a mildly elevated eosinophil count on routine bloodwork almost certainly reflects that rather than anything more serious.
How Doctors Investigate Persistent Eosinophilia
When eosinophils remain elevated without an obvious cause like allergies or a recent infection, doctors work through a systematic process. The first step is usually repeating the blood count to confirm the elevation is real and persistent, not a one-time fluctuation. Travel history, medication review, and allergy testing help rule out the most common explanations.
If counts are persistently above 1,500 and no clear cause emerges, additional blood tests may include vitamin B12, a marker called tryptase, and IgE levels (an antibody associated with allergic responses). Genetic testing for a specific mutation called FIP1L1-PDGFRA helps identify the most treatable form of eosinophilic leukemia. When counts are markedly elevated, especially above 5,000, a bone marrow biopsy is typically part of the workup. Imaging scans and heart and lung function tests may follow if there’s concern about organ damage from the eosinophils themselves.
The pattern matters as much as the number. A single elevated reading is very different from counts that climb steadily over weeks. Eosinophilia paired with unexplained weight loss, night sweats, an enlarged spleen, or organ dysfunction gets evaluated more aggressively than an isolated lab finding in someone who feels fine.
Eosinophils as a Prognostic Marker in Known Cancer
Interestingly, in people already diagnosed with cancer, higher eosinophil levels can sometimes signal a better response to treatment rather than a worse outcome. In non-small cell lung cancer patients receiving immunotherapy, those with eosinophil percentages of 1.7% or higher before treatment had a median overall survival of nearly 20 months, compared to 13.5 months for those with lower levels. An early rise in eosinophils after starting immunotherapy was also linked to better responses.
This reflects the dual role eosinophils play in the immune system. While out-of-control eosinophil production can signal a blood cancer, eosinophils also participate in the body’s anti-tumor immune response. In the context of immunotherapy, a healthy eosinophil presence may indicate a more active immune system that’s better equipped to fight the cancer.